CBI team arrests Joint Drug Controller for accepting bribe from a private company director

New Delhi: The Central Bureau of Investigation has apprehended a Joint Drug Controller (JDC), posted at CDSCO (Central Drugs Standard Control Organisation()Headquarters, New Delhi and a director of private company based at Delhi in an alleged bribery of Rs. four lakh.

A case was registered against a Joint Drug Controller (India) (JDC), CDSCO Headquarters, New Delhi and others including Directors, Associate Vice President & Head-National Regulatory Affairs (NRA) of separate private companies, two based at New Delhi and another at Bengaluru; Assistant Drug Inspector (ADI), CDSCO, New Delhi and other unknown officials of CDSCO. It was alleged in FIR that the accused was trying to exert undue influence on officers of CDSCO under Directorate General of Health Services. It is alleged that influence was for waiving the Phase III trial of “Insulin Aspart Injection” and the accused agreed to pay bribe amount of Rs.9,00,000/- to JDC for favorably processing the said three files related to private company based at Bangalore and also for favourably recommending the file of “Insulin Aspart injection” to the Subject Expert Committee (SEC) meeting.

In fact, CBI had laid a trap wherein the JDC of CDSCO was caught while accepting bribe of Rs. 4,00,000/- from the Director of Delhi based private company and meanwhile, the said Director of Delhi based private company was also caught with Drug Controller.

Related Posts

Over-the-counter sale of cough syrup barred

Following the Drugs Rules amendment, lozenges, pills, and tablets for cough will still be available over the counter; 24 children in M.P. died after consuming adulterated cough syrup last year…

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

Mumbai: On Tuesday, the FDA said it had sealed a cosmetic manufacturing factory in Bhiwandi for allegedly misleading consumers on e-commerce platforms by labelling its products as sulfate-free and paraben-free. The stock…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Over-the-counter sale of cough syrup barred

Over-the-counter sale of cough syrup barred

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

No cough syrups without a doctor’s prescription – New rules announced

No cough syrups without a doctor’s prescription – New rules announced

CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing

CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing